Cargando…

A New Bevacizumab Carrier for Intravitreal Administration: Focus on Stability

Bevacizumab (BVZ) is a monoclonal antibody that binds to human vascular endothelial growth factor A (VEGF-A) and inhibits the interaction between VEGF-A and VEGF receptors, thus blocking the angiogenesis. Repeated intravitreal injections of BVZ for the treatment of ocular pathologies that present an...

Descripción completa

Detalles Bibliográficos
Autores principales:	Chirio, Daniela, Peira, Elena, Sapino, Simona, Chindamo, Giulia, Oliaro-Bosso, Simonetta, Adinolfi, Salvatore, Dianzani, Chiara, Baratta, Francesca, Gallarate, Marina
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2021
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8071554/ https://www.ncbi.nlm.nih.gov/pubmed/33921167 http://dx.doi.org/10.3390/pharmaceutics13040560

Ejemplares similares

Assessment of In-Situ Gelling Microemulsion Systems upon Temperature and Dilution Condition for Corneal Delivery of Bevacizumab
por: Peira, Elena, et al.
Publicado: (2021)

Thermosensitive Nanocomposite Hydrogels for Intravitreal Delivery of Cefuroxime
por: Sapino, Simona, et al.
Publicado: (2019)

Recent Advances in Nanosystems and Strategies for Vaginal Delivery of Antimicrobials
por: Chindamo, Giulia, et al.
Publicado: (2021)

Development of Solid Lipid Nanoparticles by Cold Dilution of Microemulsions: Curcumin Loading, Preliminary In Vitro Studies, and Biodistribution
por: Chirio, Daniela, et al.
Publicado: (2019)

Calcium Phosphate-Coated Lipid Nanoparticles as a Potential Tool in Bone Diseases Therapy
por: Sapino, Simona, et al.
Publicado: (2021)

Bone Diseases: Current Approach and Future Perspectives in Drug Delivery Systems for Bone Targeted Therapeutics
por: Chindamo, Giulia, et al.
Publicado: (2020)

Ocular Drug Delivery: A Special Focus on the Thermosensitive Approach
por: Sapino, Simona, et al.
Publicado: (2019)

Nanocarriers in Veterinary Medicine: A Challenge for Improving Osteosarcoma Conventional Treatments
por: Sapino, Simona, et al.
Publicado: (2022)

Naked and Decorated Nanoparticles Containing H(2)S-Releasing Doxorubicin: Preparation, Characterization and Assessment of Their Antitumoral Efficiency on Various Resistant Tumor Cells
por: Peira, Elena, et al.
Publicado: (2022)

Development of ARPE-19-Equipped Ocular Cell Model for In Vitro Investigation on Ophthalmic Formulations
por: Sapino, Simona, et al.
Publicado: (2023)

Stearoyl-Chitosan Coated Nanoparticles Obtained by Microemulsion Cold Dilution Technique
por: Chirio, Daniela, et al.
Publicado: (2018)

Doxorubicin-Loaded Lipid Nanoparticles Coated with Calcium Phosphate as a Potential Tool in Human and Canine Osteosarcoma Therapy
por: Chirio, Daniela, et al.
Publicado: (2022)

Developing Actively Targeted Nanoparticles to Fight Cancer: Focus on Italian Research
por: Argenziano, Monica, et al.
Publicado: (2021)

Towards a metabolomic approach to investigate iron–sulfur cluster biogenesis
por: Marengo, Mauro, et al.
Publicado: (2022)

Cannabis-Based Oral Emulsion for Medical Purposes to Meet the Needs of Patients: Formulation, Quality and Stability
por: Baratta, Francesca, et al.
Publicado: (2022)

Intravitreal administration of bevacizumab: pros and cons
por: Dashti-Khavidaki, Simin, et al.
Publicado: (2015)

Development and Characterization of Solid Lipid Nanoparticles Loaded with a Highly Active Doxorubicin Derivative
por: Stella, Barbara, et al.
Publicado: (2018)

Intravitreal bevacizumab
por: Khamar, Bakulesh M
Publicado: (2018)

Pharmacokinetics of bevacizumab after topical and intravitreal administration in human eyes
por: Moisseiev, Elad, et al.
Publicado: (2013)

Intravitreal bevacizumab administration for the treatment of chronic central serous chorioretinopathy
por: Alishiri, Aliagha, et al.
Publicado: (2019)

Evaluation of babies with retinopathy of prematurity following intravitreal bevacizumab administration
por: Sahin, Ozlem, et al.
Publicado: (2023)

Curcumin-Loaded Solid Lipid Nanoparticles Bypass P-Glycoprotein Mediated Doxorubicin Resistance in Triple Negative Breast Cancer Cells
por: Fathy Abd-Ellatef, Gamal-Eldein, et al.
Publicado: (2020)

Intravitreal bevacizumab: an analysis of the evidence
por: Smit, Derrick P, et al.
Publicado: (2007)

Characterization of the Channel Constriction Allowing the Access of the Substrate to the Active Site of Yeast Oxidosqualene Cyclase
por: Oliaro-Bosso, Simonetta, et al.
Publicado: (2011)

Pharmacokinetics of intravitreal bevacizumab (Avastin(®)) in rabbits
por: Sinapis, Christos I, et al.
Publicado: (2011)

Response of Diabetic Papillopathy to Intravitreal Bevacizumab
por: Al-Dhibi, Hassan, et al.
Publicado: (2011)

Erectile Dysfunction Following Intravitreal Bevacizumab
por: Yohendran, Jayshan, et al.
Publicado: (2010)

Severe epistaxis related to intravitreal bevacizumab
por: Otten, Leila S., et al.
Publicado: (2019)

Intravitreal triamcinolone acetate for radiation maculopathy recalcitrant to high-dose intravitreal bevacizumab
por: Kaplan, Richard I, et al.
Publicado: (2017)

Intravitreal bevacizumab (avastin) for circumscribed choroidal hemangioma
por: Mandal, Subrata, et al.
Publicado: (2011)

Retinal Angiomatous Proliferation and Intravitreal Bevacizumab Injection
por: Kang, Jae Hoon, et al.
Publicado: (2007)

Intravitreal Bevacizumab for Treatment of Diabetic Macular Edema
por: Seo, Jeong Won, et al.
Publicado: (2009)

Intravitreal bevacizumab and diabetic papillopathy with macular edema
por: Joob, Beuy, et al.
Publicado: (2012)

Case of endophthalmitis following intravitreal injections of bevacizumab
por: Komori, Shinya, et al.
Publicado: (2010)

Application of Intravitreal Bevacizumab for Circumscribed Choroidal Hemangioma
por: Sagong, Min, et al.
Publicado: (2009)

Intravitreal injection of Bevacizumab in diabetic macular edema
por: Ateeq, Asim, et al.
Publicado: (2014)

Intravitreal Bevacizumab for Treatment of Central Serous Chorioretinopathy
por: Ünlü, Cihan, et al.
Publicado: (2016)

Role of Intravitreal Bevacizumab in Management of Eale’s Disease
por: Mehboob, Mohammad Asim, et al.
Publicado: (2018)

Dramatic response to intravitreal Bevacizumab in hypertensive retinopathy
por: Padhy, Srikant, et al.
Publicado: (2018)

The Effect of Intravitreal Bevacizumab on Central Serous Chorioretinopathy
por: Maleki, Alireza, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_oirvk3pu78j75p7h216ifv01rk